An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28  days to & lt;  6 years with chronic kidney disease receiving dialysis

ConclusionsIn conclusion, a single 0.25  mg/kg dose of cinacalcet was evaluated to be a safe starting dose in these children aged<  6 years.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research